Fezagepras (PBI-4050) A Free Fatty Acid Mimetic for the Treatment of NAFLD

March 5, 2020
Previous Flipbook
PBI-4050 reduces angio-proliferative pulmonary arterial hypertension
PBI-4050 reduces angio-proliferative pulmonary arterial hypertension

Next Flipbook
Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation
Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation